AI
Sunday, August 18, 2019 2:08:19 PM
FOMX - Momentum Still Going - Can We Hit The 3rd Target!
Foamix Pharmaceuticals Ltd . is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.
P/E Current
-1.64
P/E Ratio (with extraordinary items)
-2.3
SHORT INTEREST
2.33M 07/31/19
Average Recommendation: BUY
Average Target Price: 15.60
Foamix Pharmaceuticals Ltd . is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.
P/E Current
-1.64
P/E Ratio (with extraordinary items)
-2.3
SHORT INTEREST
2.33M 07/31/19
Average Recommendation: BUY
Average Target Price: 15.60
Official InvestorsHub (IHUB) Profile for TopMarketGainers.com. Since 2009,
we are the #1 Source For #FREE Winning #NASDAQ & #NYSE-Listed Alerts!
IHUB Board: https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
